Literature DB >> 31481632

β2 adrenergic receptor polymorphisms and COPD exacerbations: a complicated story.

Wassim W Labaki1, MeiLan K Han2.   

Abstract

Entities:  

Keywords:  COPD exacerbations

Mesh：

Substances：

Year:  2019        PMID： 31481632      PMCID： PMC6918951          DOI： 10.1136/thoraxjnl-2019-213697

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  13 in total

1.  Genetic influences on Chronic Obstructive Pulmonary Disease - a twin study.

Authors:  Truls Ingebrigtsen; Simon F Thomsen; Jørgen Vestbo; Sophie van der Sluis; Kirsten O Kyvik; Edwin K Silverman; Magnus Svartengren; Vibeke Backer
Journal:  Respir Med       Date:  2010-06-11       Impact factor: 3.415

2.  β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study.

Authors:  Truls Sylvan Ingebrigtsen; Jørgen Vestbo; Line Rode; Jacob Louis Marott; Peter Lange; Børge G Nordestgaard
Journal:  Thorax       Date:  2019-09-03       Impact factor: 9.139

3.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

4.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

5.  Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.

Authors:  Klaus F Rabe; Leonardo M Fabbri; Elliot Israel; Harald Kögler; Kathrin Riemann; Hendrik Schmidt; Thomas Glaab; Claus F Vogelmeier
Journal:  Lancet Respir Med       Date:  2013-12-05       Impact factor: 30.700

6.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

Authors:  S A Green; J Turki; M Innis; S B Liggett
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

7.  Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.

Authors:  MeiLan K Han; Pedro M Quibrera; Elizabeth E Carretta; R Graham Barr; Eugene R Bleecker; Russell P Bowler; Christopher B Cooper; Alejandro Comellas; David J Couper; Jeffrey L Curtis; Gerard Criner; Mark T Dransfield; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Jerry A Krishnan; Carlos H Martinez; Cheryl B Pirozzi; Wanda K O'Neal; Stephen Rennard; Donald P Tashkin; Jadwiga A Wedzicha; Prescott Woodruff; Robert Paine; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2017-06-28       Impact factor: 30.700

8.  Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.

Authors:  Louise V Wain; Nick Shrine; María Soler Artigas; A Mesut Erzurumluoglu; Boris Noyvert; Lara Bossini-Castillo; Ma'en Obeidat; Amanda P Henry; Michael A Portelli; Robert J Hall; Charlotte K Billington; Tracy L Rimington; Anthony G Fenech; Catherine John; Tineka Blake; Victoria E Jackson; Richard J Allen; Bram P Prins; Archie Campbell; David J Porteous; Marjo-Riitta Jarvelin; Matthias Wielscher; Alan L James; Jennie Hui; Nicholas J Wareham; Jing Hua Zhao; James F Wilson; Peter K Joshi; Beate Stubbe; Rajesh Rawal; Holger Schulz; Medea Imboden; Nicole M Probst-Hensch; Stefan Karrasch; Christian Gieger; Ian J Deary; Sarah E Harris; Jonathan Marten; Igor Rudan; Stefan Enroth; Ulf Gyllensten; Shona M Kerr; Ozren Polasek; Mika Kähönen; Ida Surakka; Veronique Vitart; Caroline Hayward; Terho Lehtimäki; Olli T Raitakari; David M Evans; A John Henderson; Craig E Pennell; Carol A Wang; Peter D Sly; Emily S Wan; Robert Busch; Brian D Hobbs; Augusto A Litonjua; David W Sparrow; Amund Gulsvik; Per S Bakke; James D Crapo; Terri H Beaty; Nadia N Hansel; Rasika A Mathias; Ingo Ruczinski; Kathleen C Barnes; Yohan Bossé; Philippe Joubert; Maarten van den Berge; Corry-Anke Brandsma; Peter D Paré; Don D Sin; David C Nickle; Ke Hao; Omri Gottesman; Frederick E Dewey; Shannon E Bruse; David J Carey; H Lester Kirchner; Stefan Jonsson; Gudmar Thorleifsson; Ingileif Jonsdottir; Thorarinn Gislason; Kari Stefansson; Claudia Schurmann; Girish Nadkarni; Erwin P Bottinger; Ruth J F Loos; Robin G Walters; Zhengming Chen; Iona Y Millwood; Julien Vaucher; Om P Kurmi; Liming Li; Anna L Hansell; Chris Brightling; Eleftheria Zeggini; Michael H Cho; Edwin K Silverman; Ian Sayers; Gosia Trynka; Andrew P Morris; David P Strachan; Ian P Hall; Martin D Tobin
Journal:  Nat Genet       Date:  2017-02-06       Impact factor: 38.330

9.  The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.

Authors:  Noura Al-Jameil; Amina A Hassan; Rana Hassanato; Sree R Isac; Maram Al Otaiby; Fadwa Al-Shareef; Basmah Al-Maarik; Iman Al Ajeyan; Khloud Al-Bahloul; Samina Ghani; Dana Al-Torbak
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

10.  Prediction of acute respiratory disease in current and former smokers with and without COPD.

Authors:  Russell P Bowler; Victor Kim; Elizabeth Regan; André A A Williams; Stephanie A Santorico; Barry J Make; David A Lynch; John E Hokanson; George R Washko; Peter Bercz; Xavier Soler; Nathaniel Marchetti; Gerard J Criner; Joe Ramsdell; MeiLan K Han; Dawn Demeo; Antonio Anzueto; Alejandro Comellas; James D Crapo; Mark Dransfield; J Michael Wells; Craig P Hersh; Neil MacIntyre; Fernando Martinez; Hrudaya P Nath; Dennis Niewoehner; Frank Sciurba; Amir Sharafkhaneh; Edwin K Silverman; Edwin J R van Beek; Carla Wilson; Christine Wendt; Robert A Wise
Journal:  Chest       Date:  2014-10       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.